Can a blood test provide cancer risk for diabetic?
Elevated IL-6 Levels and Cancer Risk in Type 2 Diabetes: A New Predictive Tool?
Topline:
Recent findings suggest that elevated interleukin (IL)-6 levels are associated with an increased risk of obesity-related cancers in patients newly diagnosed with type 2 diabetes (T2D). A simple blood test may help identify individuals at higher risk.
Study Details:
This study explores the link between inflammation markers, particularly IL-6, and t…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.